Gemina Laboratories Ltd.
GLABF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | -$0 | $15 | $1 | $42 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $19 | $38 | $35 | $14 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $24 | $71 | $71 | $111 |
| Total Curr. Assets | $43 | $124 | $106 | $167 |
| Property Plant & Equip (Net) | $30 | $45 | $315 | $346 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $718 | $994 | $994 | $994 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $16 | $22 | $22 | $22 |
| Total NC Assets | $764 | $1,062 | $1,332 | $1,363 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $807 | $1,186 | $1,438 | $1,530 |
| Liabilities | – | – | – | – |
| Payables | $2,078 | $2,919 | $2,856 | $2,513 |
| Short-Term Debt | $174 | $244 | $1,098 | $1,256 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,026 | $2,418 | $1,743 | $1,021 |
| Total Curr. Liab. | $4,278 | $5,581 | $5,698 | $4,790 |
| LT Debt | $0 | $0 | $175 | $201 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $175 | $201 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $275 | $298 |
| Total Liabilities | $4,278 | $5,581 | $5,873 | $4,991 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $9,220 | $12,774 | $11,986 | $12,087 |
| Retained Earnings | -$15,888 | -$21,599 | -$20,839 | -$19,418 |
| AOCI | $3,198 | $4,431 | $4,418 | $3,869 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$3,471 | -$4,395 | -$4,435 | -$3,461 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $807 | $1,186 | $1,438 | $1,530 |
| Net Debt | $174 | $229 | $1,273 | $1,415 |